Table 1.
Overall results of cases of acute pancreatitis associated with viral infections in case report and case-series studies
| Number; Male/female |
Median age in years (range) | Method of diagnosis of infection | Therapy | Ref | |
|---|---|---|---|---|---|
| HBV | 6/2 | 44 (27-64) | PCR for HBV DNA | NR | (15, 16, 81, 84) |
| HCV | 8/4 | 50 (38-65) | PCR for HCV RNA | Stopping use of Peginterferon | (17-19, 85) |
| HAV | 27/14 13 NR |
16 (2-81) | anti-HAV IgM & RNA | Conservative surgery, and hemodialysis |
(86) |
| HEV | 36/2 18 NR |
28 (7-54) | anti-HEV IgM & RNA | Conservative, surgery, and hemodialysis |
(82, 87) |
| SARS-CoV-2 | 28/34 | 42 (7-76) | PCR for SARS-CoV-2 RNA | NR | (30) |
| VZV | 5/6 | 44 (2-86) | IgM antibodies & VZV DNA | Acyclovir | (32-39, 88-91) |
| CMV | 6/3 | 45 (21-75) | IgM antibodies & CMV DNA | Ganciclovir | (40-44, 92, 93) |
| EBV | 6/10 | 16 (3–39) | IgM antibody | Acyclovir & supportive | (48, 94, 95) |
| HSV | 3/2 | 24 (21-73) | Cowdry type A Inclusions, IgM & DNA HSV |
NR | (49-51, 96, 97) |
| HIV | 6/2 | 37 (17-52) | p24 HIV-1 antigen and PCR for HIV RNA | Stopping use of antiretroviral | (98-104) |
| INFLUENZA | 2/1 | 37 (19-42) | PCR for influenza RNA | Oseltamivir | (61-63) |
| COXSACKIE VIRUS | 2/2 19 NR |
56 (39-67) | IgM titer against CV A4, B1, B2, B4 and B5 | NR | (64, 65, 105-107) |
| ROTAVIRUS | 4/1 | 2 (1-10) | Stool examination with culture and Immuno-chromatography kit | Intravenous rehydration | (67) |
| MUMPS | 2/3 | 46 (19-72) | IgM antibody | Symptomatic and supportive |
(73, 75, 108, 109) |
| MEASLES | 2/2 | 16 (2-22) | IgM antibody | Symptomatic and supportive |
(76-79) |
NR: not reported.